Literature DB >> 6106100

Prostacyclin increases cyclic-nucleotide responsiveness of lymphocytes from patients with systemic sclerosis.

J D Kirby, D R Lima, P M Dowd, S Kilfeather, P Turner.   

Abstract

Low cyclic-AMP levels within lymphocytes from five patients with systemic sclerosis showed a striking increase in response to isoprenaline after intravenous infusion of prostacyclin.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6106100     DOI： 10.1016/s0140-6736(80)91888-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  5 in total

Review 1.  Clinical pharmacology in the last decade.

Authors:  P Turner
Journal:  Postgrad Med J       Date:  1981-08       Impact factor: 2.401

2.  Effects of phosphodiesterase type 5 inhibitors on Raynaud's phenomenon.

Authors:  Yasuyuki Kamata; Seiji Minota
Journal:  Rheumatol Int       Date:  2014-05-01       Impact factor: 2.631

3.  Prostaglandin-mediated inhibition of lymphokine secretion in normal individuals and patients with progressive systemic sclerosis (scleroderma, PSS).

Authors:  R H Kelly; D H Miller; G P Rodnan; J Hagmann
Journal:  Agents Actions       Date:  1982-10

4.  Abnormal monocyte cytotoxicity and cyclic-AMP levels in systemic sclerosis.

Authors:  T Herlin; J Eggert; K Kragballe; H Zachariae
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

5.  Cyclic adenine nucleotide levels in lymphocytes from patients with systemic sclerosis: efficiency of prostaglandin infusions.

Authors:  I B Kovacs; P M Dowd; J D Kirby; P Turner
Journal:  Postgrad Med J       Date:  1983-04       Impact factor: 2.401
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.